Delivery Order SPE2DR25D2013-SPE2DR26F5QQX
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $39,494.93 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on December 9, 2025, with an ultimate completion date of December 10, 2025. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,077.82 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used primarily for chronic obstructive pulmonary disease management. The competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract performs in Conshohocken, Pennsylvania, at the vendor's corporate office location. This...
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,903.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on December 4, 2025, with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,156.22 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $10,859.04 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $13,997.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters. The delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $88,278.99 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award, announced on September 8, 2025, with an ultimate completion date of September 9, 2025, was issued under a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order valued at $10,092.48 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication commonly used in respiratory disease management. The contract is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...